Skip to main content

Table 1 Baseline data of studied patients

From: Transthoracic sonographic scores in evaluating the success of different scelerosing modalities in patients with malignant pleural effusion

 

N= 100

Age (mean± SD, years)

56.87 ± 22.87

Age groups

 ˃18–24 years

11 (11.0%)

 25–64 years

59 (59.0%)

 ≥ 65 years

30 (30.0%)

Sex

 Male

57 (57.0%)

 Female

43 (43.0%)

Smoking status

 Smoker

60 (60.0%)

 Non-smoker

9 (9.0%)

 Ex-smoker

31 (31.0%)

Comorbidities≠

 None

53 (53.0%)

 Hypertension

24 (24.0%)

 Cardiac diseases

13 (13.0%)

 Diabetes mellitus

10 (10.0%)

Occupation

 Housewife

31 (31.0%)

 Employee

35 (35.0%)

 Farmer

27 (27.0%)

 Unemployee

7 (7.0%)

Complaints

 Dyspnea

100 (100.0%)

 Chest pain

31 (31.0%)

 Cough

37 (37.0%)

 Chest pain and cough

24 (24.0%)

mMRC dyspnea scale

 II

5 (5.0%)

 III

59 (59.0%)

 IV

36 (36.0%)

Baseline ultrasound findings

 Effusion

100(100%)

 Pleural nodules

50 (50%)

 Pleural thickening (mm) (%, mean ± SD, range)

75 (75%), 11.35 ± 5.54 (1.0–22.0)

 Right pleural effusion

60 (60%)

 Left pleural effusion

40 (40%)

  1. mMRC modified medical research council